RxDoctor Payments Data

Christopher Lyerly, DPM

Foot & Ankle Surgery · Philadelphia, PANPI 1508345703

Payments from drug & device makers

$4,064in general payments, 2019–2025

Across 63 payments — averaging $64.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$1K
  • Liberty Surgical Inc.$960
  • Stryker$411
  • Johnson & Johnson$183
  • Integra Lifesciences Corporation$170
  • Treace Medical Concepts, Inc.$157
  • plus $797 from 15 others

What the payments were for

  • Speaking & faculty fees$622%
  • Food & beverage$3,04275%
  • Education$96024%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,064 in reported general payments places this provider in the 60th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$70,189
Medicare patients
198
Services billed
934

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin67$1,858
Ciclopirox37$1,081
Terbinafine Hcl26$679
Pregabalin20$331
Methylprednisolone35$314
Ibuprofen14$123
Meloxicam43$111
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$50

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →